

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | regulation of RIG-I signaling pathway (GO:0039535) | 9.82654760 |
| 2 | regulation of viral-induced cytoplasmic pattern recognition receptor signaling pathway (GO:0039531) | 8.53194352 |
| 3 | negative regulation of thymocyte apoptotic process (GO:0070244) | 5.17367107 |
| 4 | rRNA methylation (GO:0031167) | 4.97132305 |
| 5 | negative regulation of T cell apoptotic process (GO:0070233) | 4.80820905 |
| 6 | kynurenine metabolic process (GO:0070189) | 4.78899516 |
| 7 | negative regulation of calcium ion transport into cytosol (GO:0010523) | 4.74372242 |
| 8 | purine nucleotide salvage (GO:0032261) | 4.55672295 |
| 9 | tryptophan metabolic process (GO:0006568) | 4.54883223 |
| 10 | thrombin receptor signaling pathway (GO:0070493) | 4.52652243 |
| 11 | rRNA modification (GO:0000154) | 4.42688283 |
| 12 | nucleotide salvage (GO:0043173) | 4.40481517 |
| 13 | hemoglobin metabolic process (GO:0020027) | 4.30007758 |
| 14 | regulation of response to osmotic stress (GO:0047484) | 4.20919454 |
| 15 | rRNA catabolic process (GO:0016075) | 4.19946964 |
| 16 | phosphatidylglycerol biosynthetic process (GO:0006655) | 4.18884384 |
| 17 | cardiolipin metabolic process (GO:0032048) | 4.16659490 |
| 18 | positive regulation of histone H3-K4 methylation (GO:0051571) | 3.91439339 |
| 19 | indolalkylamine catabolic process (GO:0046218) | 3.82091946 |
| 20 | tryptophan catabolic process (GO:0006569) | 3.82091946 |
| 21 | indole-containing compound catabolic process (GO:0042436) | 3.82091946 |
| 22 | nucleoside salvage (GO:0043174) | 3.79315936 |
| 23 | AMP metabolic process (GO:0046033) | 3.79187982 |
| 24 | DNA strand renaturation (GO:0000733) | 3.70346482 |
| 25 | ADP metabolic process (GO:0046031) | 3.69714345 |
| 26 | positive regulation of natural killer cell mediated cytotoxicity (GO:0045954) | 3.68454297 |
| 27 | positive regulation by host of viral transcription (GO:0043923) | 3.64458879 |
| 28 | negative regulation of lymphocyte apoptotic process (GO:0070229) | 3.57638780 |
| 29 | ribosome assembly (GO:0042255) | 3.49692379 |
| 30 | IMP biosynthetic process (GO:0006188) | 3.49312446 |
| 31 | regulation of histone H3-K27 methylation (GO:0061085) | 3.49076939 |
| 32 | replication fork processing (GO:0031297) | 3.48885828 |
| 33 | GMP metabolic process (GO:0046037) | 3.47249275 |
| 34 | ribonucleoside diphosphate metabolic process (GO:0009185) | 3.46117381 |
| 35 | viral mRNA export from host cell nucleus (GO:0046784) | 3.45341656 |
| 36 | positive regulation of natural killer cell mediated immunity (GO:0002717) | 3.43664754 |
| 37 | intra-S DNA damage checkpoint (GO:0031573) | 3.41517875 |
| 38 | purine nucleobase biosynthetic process (GO:0009113) | 3.33054485 |
| 39 | pyrimidine deoxyribonucleotide catabolic process (GO:0009223) | 3.30279879 |
| 40 | positive regulation of gamma-delta T cell activation (GO:0046645) | 3.30184039 |
| 41 | cellular hyperosmotic response (GO:0071474) | 3.30137488 |
| 42 | organelle disassembly (GO:1903008) | 3.25941488 |
| 43 | pyrimidine nucleotide catabolic process (GO:0006244) | 3.23029436 |
| 44 | maintenance of fidelity involved in DNA-dependent DNA replication (GO:0045005) | 3.20133320 |
| 45 | negative regulation of DNA-dependent DNA replication (GO:2000104) | 3.19756643 |
| 46 | positive regulation of interleukin-8 secretion (GO:2000484) | 3.19270174 |
| 47 | import into cell (GO:0098657) | 3.19168739 |
| 48 | nucleoside diphosphate biosynthetic process (GO:0009133) | 3.16986701 |
| 49 | telomere maintenance via semi-conservative replication (GO:0032201) | 3.14622439 |
| 50 | regulation of superoxide anion generation (GO:0032928) | 3.10760475 |
| 51 | regulation of interleukin-8 secretion (GO:2000482) | 3.09410962 |
| 52 | positive regulation of alpha-beta T cell proliferation (GO:0046641) | 3.08286581 |
| 53 | positive regulation of histone methylation (GO:0031062) | 3.07677417 |
| 54 | IMP metabolic process (GO:0046040) | 3.07645049 |
| 55 | NIK/NF-kappaB signaling (GO:0038061) | 3.07613954 |
| 56 | regulation of thymocyte apoptotic process (GO:0070243) | 3.05045132 |
| 57 | nucleotide-excision repair, DNA gap filling (GO:0006297) | 3.02131703 |
| 58 | indolalkylamine metabolic process (GO:0006586) | 2.98744820 |
| 59 | mitotic G2 DNA damage checkpoint (GO:0007095) | 2.98463122 |
| 60 | negative regulation of myeloid cell apoptotic process (GO:0033033) | 2.97016747 |
| 61 | modulation by host of viral transcription (GO:0043921) | 2.93997684 |
| 62 | modulation by host of symbiont transcription (GO:0052472) | 2.93997684 |
| 63 | regulation of natural killer cell mediated cytotoxicity (GO:0042269) | 2.90664090 |
| 64 | regulation of natural killer cell mediated immunity (GO:0002715) | 2.90664090 |
| 65 | necroptotic process (GO:0070266) | 2.89827563 |
| 66 | nucleoside diphosphate catabolic process (GO:0009134) | 2.88694498 |
| 67 | deoxyribonucleoside monophosphate metabolic process (GO:0009162) | 2.86366571 |
| 68 | regulation of glomerular filtration (GO:0003093) | 2.85034673 |
| 69 | parturition (GO:0007567) | 2.84703440 |
| 70 | eye photoreceptor cell differentiation (GO:0001754) | 2.83958548 |
| 71 | photoreceptor cell differentiation (GO:0046530) | 2.83958548 |
| 72 | purine-containing compound salvage (GO:0043101) | 2.81361706 |
| 73 | phosphorylated carbohydrate dephosphorylation (GO:0046838) | 2.80325501 |
| 74 | inositol phosphate dephosphorylation (GO:0046855) | 2.80325501 |
| 75 | positive regulation of response to biotic stimulus (GO:0002833) | 2.79410578 |
| 76 | interferon-gamma secretion (GO:0072643) | 2.77857404 |
| 77 | purine nucleoside diphosphate metabolic process (GO:0009135) | 2.77535000 |
| 78 | purine ribonucleoside diphosphate metabolic process (GO:0009179) | 2.77535000 |
| 79 | DNA strand elongation involved in DNA replication (GO:0006271) | 2.76815839 |
| 80 | lysine catabolic process (GO:0006554) | 2.76113076 |
| 81 | lysine metabolic process (GO:0006553) | 2.76113076 |
| 82 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 2.75538090 |
| 83 | negative regulation of necroptotic process (GO:0060546) | 2.74834673 |
| 84 | modulation of transcription in other organism involved in symbiotic interaction (GO:0052312) | 2.73944873 |
| 85 | nucleobase biosynthetic process (GO:0046112) | 2.73685982 |
| 86 | regulation of exit from mitosis (GO:0007096) | 2.72968312 |
| 87 | regulation of T cell apoptotic process (GO:0070232) | 2.72223816 |
| 88 | telomere maintenance via telomere lengthening (GO:0010833) | 2.72199745 |
| 89 | regulation of tyrosine phosphorylation of Stat5 protein (GO:0042522) | 2.72076641 |
| 90 | positive regulation of leukocyte mediated cytotoxicity (GO:0001912) | 2.72016847 |
| 91 | piRNA metabolic process (GO:0034587) | 2.71942186 |
| 92 | erythrocyte maturation (GO:0043249) | 2.70367573 |
| 93 | positive regulation of tyrosine phosphorylation of Stat5 protein (GO:0042523) | 2.67929644 |
| 94 | folic acid-containing compound biosynthetic process (GO:0009396) | 2.66379190 |
| 95 | maternal behavior (GO:0042711) | 2.66352763 |
| 96 | regulation of gamma-delta T cell differentiation (GO:0045586) | 2.65234166 |
| 97 | pyrimidine-containing compound salvage (GO:0008655) | 2.64895778 |
| 98 | pyrimidine nucleoside salvage (GO:0043097) | 2.64895778 |
| 99 | protein polyglutamylation (GO:0018095) | 2.63479359 |
| 100 | I-kappaB phosphorylation (GO:0007252) | 2.59656188 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | E2F7_22180533_ChIP-Seq_HELA_Human | 6.91113711 |
| 2 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 5.62645899 |
| 3 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 4.61721202 |
| 4 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 3.82774317 |
| 5 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 3.72271037 |
| 6 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 3.61565194 |
| 7 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 3.21102011 |
| 8 | MYC_22102868_ChIP-Seq_BL_Human | 2.85662766 |
| 9 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 2.70670263 |
| 10 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 2.70092567 |
| 11 | MYB_26560356_Chip-Seq_TH2_Human | 2.50567599 |
| 12 | ZNF263_19887448_ChIP-Seq_K562_Human | 2.45647213 |
| 13 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 2.42934216 |
| 14 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 2.38989188 |
| 15 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 2.38147852 |
| 16 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.26609571 |
| 17 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 2.23138097 |
| 18 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 2.21801294 |
| 19 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 2.14406707 |
| 20 | MYB_26560356_Chip-Seq_TH1_Human | 1.94695910 |
| 21 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 1.84954783 |
| 22 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.74938190 |
| 23 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.73327947 |
| 24 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 1.69679627 |
| 25 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 1.68536795 |
| 26 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.67134436 |
| 27 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 1.66773640 |
| 28 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.66320381 |
| 29 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 1.64532512 |
| 30 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.60239801 |
| 31 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.58237766 |
| 32 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.57834882 |
| 33 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.51243078 |
| 34 | GATA3_26560356_Chip-Seq_TH2_Human | 1.51225712 |
| 35 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.51154464 |
| 36 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 1.50928472 |
| 37 | KDM5A_27292631_Chip-Seq_BREAST_Human | 1.47902140 |
| 38 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.46571448 |
| 39 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 1.45910842 |
| 40 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 1.41575936 |
| 41 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.41078846 |
| 42 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 1.37236051 |
| 43 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 1.36188866 |
| 44 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.35873925 |
| 45 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.33226895 |
| 46 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.29952860 |
| 47 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.28990991 |
| 48 | DCP1A_22483619_ChIP-Seq_HELA_Human | 1.28194774 |
| 49 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.27001993 |
| 50 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.26816341 |
| 51 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.24236648 |
| 52 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.21494783 |
| 53 | MAF_26560356_Chip-Seq_TH2_Human | 1.17898839 |
| 54 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.17749170 |
| 55 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.16798638 |
| 56 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 1.16482763 |
| 57 | E2F4_21247883_ChIP-Seq_LYMPHOBLASTOID_Human | 1.14013971 |
| 58 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 1.12599340 |
| 59 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.08330477 |
| 60 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 1.07748149 |
| 61 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.06856404 |
| 62 | MYCN_18555785_ChIP-Seq_MESCs_Mouse | 1.04977580 |
| 63 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.04862929 |
| 64 | MAF_26560356_Chip-Seq_TH1_Human | 1.02850800 |
| 65 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.02492816 |
| 66 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.01126617 |
| 67 | ZFX_18555785_ChIP-Seq_MESCs_Mouse | 0.99780309 |
| 68 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 0.98744046 |
| 69 | PADI4_21655091_ChIP-ChIP_MCF-7_Human | 0.98663274 |
| 70 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 0.98662438 |
| 71 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 0.98283997 |
| 72 | CUX1_19635798_ChIP-ChIP_MULTIPLE_HUMAN_CANCER_TYPES_Human | 0.98101833 |
| 73 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 0.97765893 |
| 74 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 0.94804098 |
| 75 | CNOT3_19339689_ChIP-ChIP_MESCs_Mouse | 0.94442418 |
| 76 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 0.93854137 |
| 77 | ELK1_19687146_ChIP-ChIP_HELA_Human | 0.93279129 |
| 78 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 0.91455621 |
| 79 | SOX2_19030024_ChIP-ChIP_MESCs_Mouse | 0.90945921 |
| 80 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 0.88612716 |
| 81 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 0.87818011 |
| 82 | KDM5B_21448134_ChIP-Seq_MESCs_Mouse | 0.87362737 |
| 83 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 0.86641730 |
| 84 | IRF1_19129219_ChIP-ChIP_H3396_Human | 0.86206930 |
| 85 | XRN2_22483619_ChIP-Seq_HELA_Human | 0.82462361 |
| 86 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 0.82360447 |
| 87 | TTF2_22483619_ChIP-Seq_HELA_Human | 0.82354193 |
| 88 | GATA1_22025678_ChIP-Seq_K562_Human | 0.82111265 |
| 89 | VDR_21846776_ChIP-Seq_THP-1_Human | 0.81726332 |
| 90 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 0.81713805 |
| 91 | YY1_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 0.81610405 |
| 92 | GABP_19822575_ChIP-Seq_HepG2_Human | 0.81123166 |
| 93 | FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.80105338 |
| 94 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 0.78791668 |
| 95 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.77792425 |
| 96 | UTX_26944678_Chip-Seq_JUKART_Human | 0.77307174 |
| 97 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 0.76749942 |
| 98 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 0.76639870 |
| 99 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.74004906 |
| 100 | VDR_22108803_ChIP-Seq_LS180_Human | 0.73908196 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002396_abnormal_hematopoietic_system | 4.69987866 |
| 2 | MP0003787_abnormal_imprinting | 3.75732810 |
| 3 | MP0009379_abnormal_foot_pigmentation | 3.36006117 |
| 4 | MP0005671_abnormal_response_to | 3.21355073 |
| 5 | MP0003806_abnormal_nucleotide_metabolis | 3.12653882 |
| 6 | MP0001188_hyperpigmentation | 3.06989696 |
| 7 | MP0010094_abnormal_chromosome_stability | 2.95394914 |
| 8 | MP0001835_abnormal_antigen_presentation | 2.70012605 |
| 9 | MP0000383_abnormal_hair_follicle | 2.65674413 |
| 10 | MP0003763_abnormal_thymus_physiology | 2.46910140 |
| 11 | MP0009333_abnormal_splenocyte_physiolog | 2.32550452 |
| 12 | MP0001800_abnormal_humoral_immune | 2.31428668 |
| 13 | MP0008058_abnormal_DNA_repair | 2.26814952 |
| 14 | MP0010678_abnormal_skin_adnexa | 2.19371467 |
| 15 | MP0005387_immune_system_phenotype | 2.10281190 |
| 16 | MP0001790_abnormal_immune_system | 2.10281190 |
| 17 | MP0002006_tumorigenesis | 2.01035266 |
| 18 | MP0002877_abnormal_melanocyte_morpholog | 1.98141058 |
| 19 | MP0008007_abnormal_cellular_replicative | 1.92817057 |
| 20 | MP0000685_abnormal_immune_system | 1.87543324 |
| 21 | MP0003075_altered_response_to | 1.83342929 |
| 22 | MP0005000_abnormal_immune_tolerance | 1.81053780 |
| 23 | MP0002160_abnormal_reproductive_system | 1.79544036 |
| 24 | MP0002723_abnormal_immune_serum | 1.79522875 |
| 25 | MP0001986_abnormal_taste_sensitivity | 1.69630199 |
| 26 | MP0002398_abnormal_bone_marrow | 1.67952351 |
| 27 | MP0006082_CNS_inflammation | 1.64162845 |
| 28 | MP0002420_abnormal_adaptive_immunity | 1.63015411 |
| 29 | MP0003111_abnormal_nucleus_morphology | 1.61032485 |
| 30 | MP0004147_increased_porphyrin_level | 1.56916454 |
| 31 | MP0002452_abnormal_antigen_presenting | 1.54944495 |
| 32 | MP0001819_abnormal_immune_cell | 1.54502764 |
| 33 | MP0003121_genomic_imprinting | 1.54492048 |
| 34 | MP0005464_abnormal_platelet_physiology | 1.52929767 |
| 35 | MP0002166_altered_tumor_susceptibility | 1.52639277 |
| 36 | MP0002405_respiratory_system_inflammati | 1.50652356 |
| 37 | MP0003252_abnormal_bile_duct | 1.48915940 |
| 38 | MP0000716_abnormal_immune_system | 1.44415941 |
| 39 | MP0005165_increased_susceptibility_to | 1.41558769 |
| 40 | MP0003718_maternal_effect | 1.40318593 |
| 41 | MP0005409_darkened_coat_color | 1.37705625 |
| 42 | MP0000689_abnormal_spleen_morphology | 1.36266276 |
| 43 | MP0003077_abnormal_cell_cycle | 1.35376390 |
| 44 | MP0005025_abnormal_response_to | 1.32759040 |
| 45 | MP0002429_abnormal_blood_cell | 1.31836374 |
| 46 | MP0002019_abnormal_tumor_incidence | 1.31178914 |
| 47 | MP0001881_abnormal_mammary_gland | 1.30490410 |
| 48 | MP0003941_abnormal_skin_development | 1.28399586 |
| 49 | MP0000015_abnormal_ear_pigmentation | 1.27555483 |
| 50 | MP0002722_abnormal_immune_system | 1.27544475 |
| 51 | MP0005174_abnormal_tail_pigmentation | 1.26895520 |
| 52 | MP0000703_abnormal_thymus_morphology | 1.24581484 |
| 53 | MP0001853_heart_inflammation | 1.20834904 |
| 54 | MP0002148_abnormal_hypersensitivity_rea | 1.17978254 |
| 55 | MP0005389_reproductive_system_phenotype | 1.15636769 |
| 56 | MP0008469_abnormal_protein_level | 1.13084311 |
| 57 | MP0004381_abnormal_hair_follicle | 1.12095033 |
| 58 | MP0008057_abnormal_DNA_replication | 1.11360929 |
| 59 | MP0010155_abnormal_intestine_physiology | 1.11172690 |
| 60 | MP0004808_abnormal_hematopoietic_stem | 1.09093025 |
| 61 | MP0001873_stomach_inflammation | 1.08115222 |
| 62 | MP0001845_abnormal_inflammatory_respons | 1.07696464 |
| 63 | MP0008875_abnormal_xenobiotic_pharmacok | 1.06537542 |
| 64 | MP0003693_abnormal_embryo_hatching | 1.06210880 |
| 65 | MP0003183_abnormal_peptide_metabolism | 1.05443215 |
| 66 | MP0009765_abnormal_xenobiotic_induced | 1.05246158 |
| 67 | MP0001730_embryonic_growth_arrest | 1.01158294 |
| 68 | MP0005451_abnormal_body_composition | 0.99956719 |
| 69 | MP0009785_altered_susceptibility_to | 0.97618841 |
| 70 | MP0003646_muscle_fatigue | 0.94327061 |
| 71 | MP0010234_abnormal_vibrissa_follicle | 0.92848355 |
| 72 | MP0005501_abnormal_skin_physiology | 0.92268189 |
| 73 | MP0005397_hematopoietic_system_phenotyp | 0.92116187 |
| 74 | MP0001545_abnormal_hematopoietic_system | 0.92116187 |
| 75 | MP0002933_joint_inflammation | 0.91380146 |
| 76 | MP0002138_abnormal_hepatobiliary_system | 0.90799198 |
| 77 | MP0002095_abnormal_skin_pigmentation | 0.90703262 |
| 78 | MP0003567_abnormal_fetal_cardiomyocyte | 0.89729597 |
| 79 | MP0003436_decreased_susceptibility_to | 0.88293901 |
| 80 | MP0000627_abnormal_mammary_gland | 0.87102885 |
| 81 | MP0003786_premature_aging | 0.87015028 |
| 82 | MP0002796_impaired_skin_barrier | 0.85425668 |
| 83 | MP0005075_abnormal_melanosome_morpholog | 0.84857874 |
| 84 | MP0003866_abnormal_defecation | 0.84343642 |
| 85 | MP0000609_abnormal_liver_physiology | 0.83940643 |
| 86 | MP0004782_abnormal_surfactant_physiolog | 0.82913830 |
| 87 | MP0005645_abnormal_hypothalamus_physiol | 0.82508689 |
| 88 | MP0005395_other_phenotype | 0.81674040 |
| 89 | MP0004957_abnormal_blastocyst_morpholog | 0.75676755 |
| 90 | MP0005410_abnormal_fertilization | 0.73125797 |
| 91 | MP0006036_abnormal_mitochondrial_physio | 0.73092474 |
| 92 | MP0005310_abnormal_salivary_gland | 0.73060475 |
| 93 | MP0009763_increased_sensitivity_to | 0.72593369 |
| 94 | MP0010771_integument_phenotype | 0.69466067 |
| 95 | MP0001502_abnormal_circadian_rhythm | 0.69261035 |
| 96 | MP0002419_abnormal_innate_immunity | 0.67303694 |
| 97 | MP0000350_abnormal_cell_proliferation | 0.65738319 |
| 98 | MP0009764_decreased_sensitivity_to | 0.65726046 |
| 99 | MP0001216_abnormal_epidermal_layer | 0.65587475 |
| 100 | MP0004484_altered_response_of | 0.64645050 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 6.11172295 |
| 2 | Abnormality of lateral ventricle (HP:0030047) | 4.73601324 |
| 3 | IgM deficiency (HP:0002850) | 4.37470662 |
| 4 | Slow saccadic eye movements (HP:0000514) | 4.18235427 |
| 5 | Agammaglobulinemia (HP:0004432) | 4.13705036 |
| 6 | Abnormality of T cell physiology (HP:0011840) | 4.10445960 |
| 7 | Autoimmune hemolytic anemia (HP:0001890) | 4.07898692 |
| 8 | Chronic mucocutaneous candidiasis (HP:0002728) | 4.04492072 |
| 9 | Recurrent cutaneous fungal infections (HP:0011370) | 4.04492072 |
| 10 | Panhypogammaglobulinemia (HP:0003139) | 3.82142954 |
| 11 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.56727653 |
| 12 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 3.37987457 |
| 13 | Abnormality of T cells (HP:0002843) | 3.32632254 |
| 14 | Chromsome breakage (HP:0040012) | 3.31956366 |
| 15 | Acute lymphatic leukemia (HP:0006721) | 3.21309743 |
| 16 | Colitis (HP:0002583) | 3.20274481 |
| 17 | Fatigue (HP:0012378) | 3.19433921 |
| 18 | Abnormality of T cell number (HP:0011839) | 3.17550437 |
| 19 | Recurrent viral infections (HP:0004429) | 3.10109348 |
| 20 | Abolished electroretinogram (ERG) (HP:0000550) | 3.06848872 |
| 21 | Mesangial abnormality (HP:0001966) | 3.02074403 |
| 22 | Chromosomal breakage induced by crosslinking agents (HP:0003221) | 2.96152052 |
| 23 | Aplastic anemia (HP:0001915) | 2.94551004 |
| 24 | Abnormality of the fingertips (HP:0001211) | 2.94505452 |
| 25 | Autoimmune thrombocytopenia (HP:0001973) | 2.79639725 |
| 26 | Abnormality of the prostate (HP:0008775) | 2.79010950 |
| 27 | T lymphocytopenia (HP:0005403) | 2.75555069 |
| 28 | Abnormality of chromosome stability (HP:0003220) | 2.73448696 |
| 29 | Encephalitis (HP:0002383) | 2.66827380 |
| 30 | Prostate neoplasm (HP:0100787) | 2.64441760 |
| 31 | Tubular atrophy (HP:0000092) | 2.59077528 |
| 32 | High pitched voice (HP:0001620) | 2.58759127 |
| 33 | Azoospermia (HP:0000027) | 2.56542792 |
| 34 | Anteriorly placed anus (HP:0001545) | 2.52087752 |
| 35 | Recurrent fungal infections (HP:0002841) | 2.48722634 |
| 36 | Abnormality of B cell number (HP:0010975) | 2.48148741 |
| 37 | Meningitis (HP:0001287) | 2.47945090 |
| 38 | Abnormality of the labia minora (HP:0012880) | 2.40348913 |
| 39 | Multiple enchondromatosis (HP:0005701) | 2.39285827 |
| 40 | Abnormality of saccadic eye movements (HP:0000570) | 2.37098134 |
| 41 | Prominent nose (HP:0000448) | 2.36259413 |
| 42 | Mediastinal lymphadenopathy (HP:0100721) | 2.35460461 |
| 43 | Dicarboxylic aciduria (HP:0003215) | 2.32719275 |
| 44 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.32719275 |
| 45 | Recurrent skin infections (HP:0001581) | 2.32623210 |
| 46 | Pustule (HP:0200039) | 2.29119058 |
| 47 | Acute myeloid leukemia (HP:0004808) | 2.28971321 |
| 48 | Abnormal rod and cone electroretinograms (HP:0008323) | 2.27567205 |
| 49 | IgG deficiency (HP:0004315) | 2.24437590 |
| 50 | Squamous cell carcinoma (HP:0002860) | 2.22484411 |
| 51 | Malignant hyperthermia (HP:0002047) | 2.21379328 |
| 52 | Inflammation of the large intestine (HP:0002037) | 2.19859795 |
| 53 | Diastasis recti (HP:0001540) | 2.18274025 |
| 54 | Onycholysis (HP:0001806) | 2.16552116 |
| 55 | Abnormality of cochlea (HP:0000375) | 2.14288557 |
| 56 | Muscle stiffness (HP:0003552) | 2.13508949 |
| 57 | Granulocytopenia (HP:0001913) | 2.12940400 |
| 58 | Abnormal spermatogenesis (HP:0008669) | 2.12506310 |
| 59 | 3-Methylglutaconic aciduria (HP:0003535) | 2.10831913 |
| 60 | Papilledema (HP:0001085) | 2.09158811 |
| 61 | Severe combined immunodeficiency (HP:0004430) | 2.07613430 |
| 62 | Neoplasm of head and neck (HP:0012288) | 2.07412079 |
| 63 | Esophageal neoplasm (HP:0100751) | 2.07412079 |
| 64 | Microretrognathia (HP:0000308) | 2.07403406 |
| 65 | Selective tooth agenesis (HP:0001592) | 2.07308111 |
| 66 | Cone-rod dystrophy (HP:0000548) | 2.07137765 |
| 67 | Pigmentary retinal degeneration (HP:0001146) | 2.03790247 |
| 68 | Abnormality of the preputium (HP:0100587) | 2.02959704 |
| 69 | IgA deficiency (HP:0002720) | 2.02906876 |
| 70 | Genetic anticipation (HP:0003743) | 2.02602348 |
| 71 | Abnormality of methionine metabolism (HP:0010901) | 2.00651719 |
| 72 | Partial agenesis of the corpus callosum (HP:0001338) | 1.98464904 |
| 73 | Progressive muscle weakness (HP:0003323) | 1.98376683 |
| 74 | Abnormal number of incisors (HP:0011064) | 1.98099775 |
| 75 | Obstructive lung disease (HP:0006536) | 1.97029683 |
| 76 | Chronic obstructive pulmonary disease (HP:0006510) | 1.97029683 |
| 77 | Myelodysplasia (HP:0002863) | 1.96326357 |
| 78 | Tubulointerstitial fibrosis (HP:0005576) | 1.96136466 |
| 79 | Gastrointestinal inflammation (HP:0004386) | 1.95681420 |
| 80 | Lymphoma (HP:0002665) | 1.95286066 |
| 81 | Vasculitis (HP:0002633) | 1.94433387 |
| 82 | Decreased central vision (HP:0007663) | 1.93364706 |
| 83 | Duplicated collecting system (HP:0000081) | 1.92552481 |
| 84 | Dyschromatopsia (HP:0007641) | 1.91159538 |
| 85 | Intellectual disability, profound (HP:0002187) | 1.90799137 |
| 86 | Potter facies (HP:0002009) | 1.88799825 |
| 87 | Facial shape deformation (HP:0011334) | 1.88799825 |
| 88 | Conjunctival telangiectasia (HP:0000524) | 1.87091478 |
| 89 | Clubbing of toes (HP:0100760) | 1.85546555 |
| 90 | Macroorchidism (HP:0000053) | 1.82608490 |
| 91 | Gastrointestinal stroma tumor (HP:0100723) | 1.80060058 |
| 92 | Insulin-resistant diabetes mellitus (HP:0000831) | 1.79778597 |
| 93 | Hypoproteinemia (HP:0003075) | 1.79063433 |
| 94 | Constricted visual fields (HP:0001133) | 1.77523753 |
| 95 | Polydipsia (HP:0001959) | 1.77476063 |
| 96 | Abnormal drinking behavior (HP:0030082) | 1.77476063 |
| 97 | Tubulointerstitial abnormality (HP:0001969) | 1.77449072 |
| 98 | Abnormal biliary tract physiology (HP:0012439) | 1.76918558 |
| 99 | Bile duct proliferation (HP:0001408) | 1.76918558 |
| 100 | Anhidrosis (HP:0000970) | 1.76500750 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TAOK3 | 5.87987216 |
| 2 | MAP4K1 | 4.70945065 |
| 3 | MAP2K3 | 4.21788149 |
| 4 | TXK | 3.29583143 |
| 5 | MAP3K14 | 3.16067390 |
| 6 | MAP2K6 | 2.78461259 |
| 7 | BCKDK | 2.73341895 |
| 8 | VRK1 | 2.57245255 |
| 9 | FES | 2.06037402 |
| 10 | PASK | 1.97400658 |
| 11 | VRK2 | 1.95706833 |
| 12 | TTK | 1.95365693 |
| 13 | CSF1R | 1.87222008 |
| 14 | KIT | 1.78002720 |
| 15 | TRPM7 | 1.76466867 |
| 16 | RIPK4 | 1.69908904 |
| 17 | JAK3 | 1.69002219 |
| 18 | MATK | 1.67204731 |
| 19 | MAP3K6 | 1.59029044 |
| 20 | STK38L | 1.53657238 |
| 21 | TAOK2 | 1.48766097 |
| 22 | PHKG1 | 1.47187075 |
| 23 | PHKG2 | 1.47187075 |
| 24 | NUAK1 | 1.45989903 |
| 25 | ITK | 1.40914630 |
| 26 | DAPK1 | 1.35140732 |
| 27 | TBK1 | 1.30532436 |
| 28 | ERN1 | 1.28244583 |
| 29 | MAPKAPK3 | 1.24247586 |
| 30 | NME2 | 1.20390724 |
| 31 | SRPK1 | 1.19405083 |
| 32 | TYRO3 | 1.16882038 |
| 33 | IKBKE | 1.15602758 |
| 34 | MAP3K5 | 1.12523574 |
| 35 | PRKCQ | 1.12027970 |
| 36 | CDK12 | 1.09120936 |
| 37 | MAP2K4 | 1.08584169 |
| 38 | PIK3CA | 1.05658721 |
| 39 | EIF2AK3 | 1.01639422 |
| 40 | ATR | 0.98968059 |
| 41 | EIF2AK1 | 0.98909865 |
| 42 | FLT3 | 0.96957936 |
| 43 | EIF2AK2 | 0.93923026 |
| 44 | LCK | 0.92044512 |
| 45 | IKBKB | 0.91186436 |
| 46 | SYK | 0.89327562 |
| 47 | CDK7 | 0.87288344 |
| 48 | NEK1 | 0.86177826 |
| 49 | STK38 | 0.80951307 |
| 50 | MAP3K13 | 0.80897975 |
| 51 | FGFR3 | 0.80135138 |
| 52 | TAF1 | 0.79874793 |
| 53 | FGFR4 | 0.79817184 |
| 54 | MAPK11 | 0.79710596 |
| 55 | ADRBK2 | 0.78990631 |
| 56 | LYN | 0.77859514 |
| 57 | ALK | 0.77118961 |
| 58 | MAP3K11 | 0.76495619 |
| 59 | RPS6KB2 | 0.70635984 |
| 60 | CDK4 | 0.69976711 |
| 61 | CSK | 0.66600412 |
| 62 | PLK3 | 0.66335225 |
| 63 | IRAK3 | 0.66289752 |
| 64 | NLK | 0.61815288 |
| 65 | GRK1 | 0.58902442 |
| 66 | RAF1 | 0.58479955 |
| 67 | ABL2 | 0.57402899 |
| 68 | BLK | 0.56219116 |
| 69 | ATM | 0.55896864 |
| 70 | GRK7 | 0.55608525 |
| 71 | SMG1 | 0.55488730 |
| 72 | BTK | 0.55215647 |
| 73 | RPS6KB1 | 0.54615293 |
| 74 | JAK2 | 0.52583287 |
| 75 | DAPK2 | 0.51376299 |
| 76 | ERBB3 | 0.51058664 |
| 77 | KDR | 0.50655526 |
| 78 | PDK1 | 0.49149704 |
| 79 | CSNK2A1 | 0.47028138 |
| 80 | ZAP70 | 0.46841425 |
| 81 | NEK6 | 0.43602810 |
| 82 | HIPK2 | 0.42579647 |
| 83 | PRPF4B | 0.39259309 |
| 84 | FYN | 0.38411921 |
| 85 | CDC7 | 0.37726455 |
| 86 | PIM2 | 0.37263419 |
| 87 | ABL1 | 0.36311221 |
| 88 | CSNK1D | 0.35087363 |
| 89 | TESK2 | 0.34749889 |
| 90 | MAPK3 | 0.30592301 |
| 91 | RPS6KA1 | 0.28344640 |
| 92 | TLK1 | 0.28282125 |
| 93 | AURKB | 0.26611806 |
| 94 | CSNK1A1 | 0.25951156 |
| 95 | CHEK1 | 0.25919085 |
| 96 | PLK1 | 0.24341390 |
| 97 | CSNK2A2 | 0.23072588 |
| 98 | MAP3K3 | 0.22010578 |
| 99 | HCK | 0.21837670 |
| 100 | BUB1 | 0.21184228 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Mismatch repair_Homo sapiens_hsa03430 | 3.77202420 |
| 2 | Homologous recombination_Homo sapiens_hsa03440 | 3.49662413 |
| 3 | DNA replication_Homo sapiens_hsa03030 | 3.33013241 |
| 4 | Primary immunodeficiency_Homo sapiens_hsa05340 | 3.30257433 |
| 5 | Allograft rejection_Homo sapiens_hsa05330 | 2.94324410 |
| 6 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 2.56576044 |
| 7 | One carbon pool by folate_Homo sapiens_hsa00670 | 2.55241126 |
| 8 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 2.54870994 |
| 9 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 2.52382056 |
| 10 | Graft-versus-host disease_Homo sapiens_hsa05332 | 2.38859489 |
| 11 | Antigen processing and presentation_Homo sapiens_hsa04612 | 2.04115567 |
| 12 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 1.90298427 |
| 13 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.83133658 |
| 14 | Base excision repair_Homo sapiens_hsa03410 | 1.80697161 |
| 15 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.77667813 |
| 16 | RNA transport_Homo sapiens_hsa03013 | 1.71426921 |
| 17 | Proteasome_Homo sapiens_hsa03050 | 1.70271891 |
| 18 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.68469908 |
| 19 | RNA polymerase_Homo sapiens_hsa03020 | 1.67813388 |
| 20 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.67520527 |
| 21 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.64865964 |
| 22 | Asthma_Homo sapiens_hsa05310 | 1.53016725 |
| 23 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 1.51235256 |
| 24 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.47937355 |
| 25 | Leishmaniasis_Homo sapiens_hsa05140 | 1.46305531 |
| 26 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.38977770 |
| 27 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.38123091 |
| 28 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.35123122 |
| 29 | Nucleotide excision repair_Homo sapiens_hsa03420 | 1.34066124 |
| 30 | Ribosome_Homo sapiens_hsa03010 | 1.33836471 |
| 31 | Measles_Homo sapiens_hsa05162 | 1.29404195 |
| 32 | Spliceosome_Homo sapiens_hsa03040 | 1.28821813 |
| 33 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 1.24543040 |
| 34 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.23555212 |
| 35 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.22965096 |
| 36 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.20841449 |
| 37 | Purine metabolism_Homo sapiens_hsa00230 | 1.19694920 |
| 38 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.19230176 |
| 39 | Non-homologous end-joining_Homo sapiens_hsa03450 | 1.14964517 |
| 40 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 1.07711560 |
| 41 | RNA degradation_Homo sapiens_hsa03018 | 1.07323962 |
| 42 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.05467533 |
| 43 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.05351527 |
| 44 | Influenza A_Homo sapiens_hsa05164 | 1.05216457 |
| 45 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 1.02842057 |
| 46 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.95725225 |
| 47 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.95290734 |
| 48 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.88452055 |
| 49 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.88281701 |
| 50 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.87779047 |
| 51 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.87426947 |
| 52 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.85208063 |
| 53 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.85116868 |
| 54 | Cell cycle_Homo sapiens_hsa04110 | 0.81189716 |
| 55 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.80831531 |
| 56 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.80288028 |
| 57 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 0.79831510 |
| 58 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.78394962 |
| 59 | Carbon metabolism_Homo sapiens_hsa01200 | 0.73331543 |
| 60 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.69566407 |
| 61 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.67795479 |
| 62 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.66037598 |
| 63 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.65633654 |
| 64 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.64170121 |
| 65 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.62008740 |
| 66 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 0.57903185 |
| 67 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.57758070 |
| 68 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.53076719 |
| 69 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.51758753 |
| 70 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.51436243 |
| 71 | Tuberculosis_Homo sapiens_hsa05152 | 0.49205926 |
| 72 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.48952009 |
| 73 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.48546966 |
| 74 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.47886506 |
| 75 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.46144762 |
| 76 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.45627752 |
| 77 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.43645929 |
| 78 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.43150810 |
| 79 | Olfactory transduction_Homo sapiens_hsa04740 | 0.42016617 |
| 80 | Apoptosis_Homo sapiens_hsa04210 | 0.41174211 |
| 81 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.40837452 |
| 82 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.40736333 |
| 83 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.40299292 |
| 84 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.39174850 |
| 85 | Viral myocarditis_Homo sapiens_hsa05416 | 0.38265421 |
| 86 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.38031991 |
| 87 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.37762549 |
| 88 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.37707353 |
| 89 | Malaria_Homo sapiens_hsa05144 | 0.36135793 |
| 90 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.35201664 |
| 91 | Peroxisome_Homo sapiens_hsa04146 | 0.35017982 |
| 92 | HTLV-I infection_Homo sapiens_hsa05166 | 0.30495385 |
| 93 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.28908286 |
| 94 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.28242000 |
| 95 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.27931772 |
| 96 | Circadian rhythm_Homo sapiens_hsa04710 | 0.27872322 |
| 97 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.24548360 |
| 98 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.23193594 |
| 99 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.22759785 |
| 100 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.22709493 |

